Skandinaviska Enskilda Banken (SEB)’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-171,000	Closed	-$34K	–	938
2022 Q4	$34K	Buy	171,000 +170,876	+137,803%	+$73.3K	﹤0.01%	831
2022 Q3	$171M	Buy	+124	New	+$85	1.32%	10
2022 Q2	–	Sell	-171,000	Closed	-$150K	–	1087
2022 Q1	$150K	Buy	+171,000	New	+$190K	﹤0.01%	905
2021 Q4	–	Sell	-186,000	Closed	-$630K	–	1084
2021 Q3	$630K	Buy	+186,000	New	+$662K	﹤0.01%	846

Other funds holding DNA.WS

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

JRCM

Jones Road Capital Management New York $55.3M AUM 29.97% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s DNA.WS Position: Q1 2023 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q1 2023, closing a stake of 171,000 shares — an estimated $34K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in DNA.WS in Q3 2021 and held it in 4 quarters. The position peaked at $171M in Q3 2022. 40 funds tracked by Wall St. Rank hold DNA.WS as of Q1 2023.

Skandinaviska Enskilda Banken (SEB) reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q1 2023 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 171,000 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q1 2023, an estimated $34K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2021 and held it in 4 quarters.
Skandinaviska Enskilda Banken (SEB)'s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $171M in Q3 2022.
40 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q1 2023.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2023, filed 11 May 2023.